small molecule

KEFLEX

CEPHALEXIN

Loss of exclusivity—loss of exclusivity

CompanyPragma →See this company's full patent-cliff portfolio

Drug detail

Brand name	KEFLEX
Active ingredient	CEPHALEXIN
Strength	EQ 500MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	CAPSULE
Route	ORAL
Modality	Small molecule
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.